BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
5.82
↓ 36% vs avg
Percentile
P93
Near historical high
Streak
1 yr
Consecutive declineContracting
Average
9.10
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.82 | -96.7% |
| 2024 | 178.86 | +1215.2% |
| 2023 | -16.04 | +10.3% |
| 2022 | -17.87 | +15.3% |
| 2021 | -21.11 | -182.2% |
| 2020 | -7.48 | -95.0% |
| 2019 | -3.84 | +60.1% |
| 2018 | -9.60 | -29.5% |
| 2017 | -7.42 | +28.3% |
| 2016 | -10.34 | - |